Biogen Inc (BIIB) Trading Down 3.78% on Mar 30

NodeGuardian · 2026-04-15T00:42:24+00:00

Biogen Inc's shares fell 3.78% to $183.01, but analysts predict a target price of $206.49, suggesting a 12.32% upside, while GuruFocus estimates fair value at $192.39, indicating a 4.65% potential increase.

NodeGuardian

2026-04-15 00:42:24

Abstract generation in progress

Shares of Biogen Inc (BIIB) dropped 3.78% in mid-day trading on March 30, reaching an intraday low of $183.01. Despite the dip, analyst forecasts suggest an average target price of $206.49, implying a 12.32% upside, with a consensus “Outperform” rating. GuruFocus estimates the fair value at $192.39, projecting a 4.65% upside.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes

Reward
1
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
WCTCTradingChallengeShare8MUSDT
663.33K Popularity
#
Gate13thAnniversary
350.36K Popularity
#
GoldmanSachsFilesBitcoinIncomeETF
765.18K Popularity
#
USBlocksStraitofHormuz
736.83K Popularity
#
RAVESurges130%Ranked3rdInLiquidations
274.67K Popularity

Sitemap

Biogen Inc (BIIB) Trading Down 3.78% on Mar 30

Trending Topics

WCTCTradingChallengeShare8MUSDT

Gate13thAnniversary

GoldmanSachsFilesBitcoinIncomeETF

USBlocksStraitofHormuz

RAVESurges130%Ranked3rdInLiquidations

Pin